Shenzhen Chipscreen Biosciences Co organizacji EV/Sales
Jaka jest wartość EV/Sales organizacji Shenzhen Chipscreen Biosciences Co?
Wartość EV/Sales organizacji Shenzhen Chipscreen Biosciences Co., Ltd. to 17.04
Jaka jest definicja EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales firm w Health Care sektor na SSE w porównaniu do Shenzhen Chipscreen Biosciences Co
Czym się zajmuję organizacja Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Firmy z ev/sales podobne do Shenzhen Chipscreen Biosciences Co
- Wartość EV/Sales organizacji Central and Eastern Europe Fund Inc to 17.00
- Wartość EV/Sales organizacji Axiom Properties to 17.00
- Wartość EV/Sales organizacji Arrow Global Plc to 17.00
- Wartość EV/Sales organizacji China Satellite Communications Co to 17.01
- Wartość EV/Sales organizacji Elemental Royalties Ltd to 17.03
- Wartość EV/Sales organizacji Eaton Vance 2021 Target Term Trust to 17.04
- Wartość EV/Sales organizacji Shenzhen Chipscreen Biosciences Co to 17.04
- Wartość EV/Sales organizacji Tree to 17.05
- Wartość EV/Sales organizacji Schroder Japan Growth Fund to 17.07
- Wartość EV/Sales organizacji Australian Foundation Investment to 17.08
- Wartość EV/Sales organizacji Liberty Broadband Corp to 17.09
- Wartość EV/Sales organizacji Aruma Resources to 17.09
- Wartość EV/Sales organizacji Crowdstrike Inc to 17.10